Latest Share Options News

Helix Resources (ASX:HLX) is set to consolidate its securities on a 1-for-35 basis, dramatically reducing the number of shares, options, and performance rights on issue. The move aims to streamline the capital structure ahead of upcoming exploration milestones.

Caspin Resources has agreed to sell its entire Mount Squires Project interest to Agrimin Limited, receiving shares, options, performance rights, and a royalty, while concentrating on advancing its high-grade Bygoo Tin Project in New South Wales.

Agrimin Limited has secured a large exploration package in Western Australia's West Musgrave region, acquiring the Mount Squires Project from Caspin Resources. The project offers promising gold and base metal targets along strike from BHP’s Nebo and Babel deposits.

Nagambie Resources has completed all conditions precedent following strong shareholder approval for an earn-in joint venture with Alkane Resources, enabling Alkane to acquire up to an 80% interest through staged funding over five years.

Chimeric Therapeutics Limited has announced a significant 100-to-1 security consolidation affecting shares, options, and performance rights, pending shareholder approval and set for implementation in April 2026.

EOS management, including CEO Dr Andreas Schwer and CFO Clive Cuthell, have exercised over 3.3 million share options, with the CEO set to sell a significant portion to fund personal commitments.

Australian Strategic Materials and Energy Fuels have amended their acquisition deal, replacing a special dividend with a direct cash payment to ASM shareholders, while maintaining the original share swap terms.

Pilot Energy has locked in a $25 million equity subscription facility with US-based LDA Capital, aiming to fast-track its carbon storage and data centre projects while reducing funding risks.

Matrix Composites & Engineering Ltd reported a $9.4 million loss for the half-year ending December 2025, driven by a 32% drop in revenue to $26.9 million. Despite the weak first half, the company anticipates a robust second half to meet or exceed last year’s full-year revenue.

Artrya Limited reported a 44% increase in its half-year loss to $10.7 million as it transitioned from development to commercial operations in the US, securing FDA clearance and signing three foundation customers. An $80 million capital raise underpins its ambitious US expansion and ongoing product development.

Wagners Holding Company Limited has reported a robust half-year result for December 2025, with revenue climbing to $251.7 million and net profit after tax soaring 70% to $21 million. Improved margins and operational efficiencies across key segments underpin the strong performance.

Osmond Resources has reported compelling high-grade assay results from its Orión EU Critical Minerals Project in Spain, confirming the potential for a large-scale deposit of titanium, zircon, and rare earth elements. These findings reinforce the project's strategic importance amid growing EU demand for critical minerals.